as on March 7, 2026 at 7:59 am IST
Day's Low
Day's High
4.44%
Downside
2.39%
Upside
52 Week's Low
52 Week's High
19.11%
Downside
206.14%
Upside
Check Aardvark Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$122.8M
EPS (TTM)
-2.94
Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
-48.06%
Compare market cap, revenue, PE, and other key metrics of Aardvark Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $122.8M | NA | NA | 0.00% | |
| BUY | $43.4B | 123.52% | 141.08 | 8.45% | |
| BUY | $121.4B | 117.39% | 31.15 | 32.94% | |
| NA | $33.1B | NA | 586.31 | 5.37% | |
| BUY | $83.3B | 65.72% | 18.98 | 31.41% |
The Aardvark Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Aardvark Therapeutics investment value today
Current value as on today
₹66,919
Returns
Returns from Aardvark Therapeutics Stock
Dollar Returns*
₹5,365 (+5.36%)
Search interest for Aardvark Therapeutics Stock has increased by 126% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:126% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
![]()
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 31.1% return, outperforming this stock by 73.4%
Price Dip
![]()
In the last 7 days, AARD stock has moved down by -53.2%
| Organisation | Aardvark Therapeutics |
| Headquarters | 4370 La Jolla Village Drive, San Diego, CA, United States, 92122 |
| CEO | Dr. Tien-Li Lee M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Nelson B. Sun M.B.A. | CFO & COO |
Dr. Zhenhuan Zheng Ph.D. | Chief Research Officer |
Dr. Tien-Li Lee M.D. | CEO, Secretary & Director |
Dr. Bryan Jones Ph.D. | Chief Executive Officer of Ardia |
Mr. Christian Zapf J.D. | General Counsel |
Dr. Dvorit Samid Ph.D. | Executive Vice President of Medical Affairs |
Mr. Ron Lewis II, Ph.D. | VP & Head of CMC |
Dr. Terrie Kellmeyer Ph.D. | Senior Vice President of Regulatory Affairs |
Dr. Manasi Sinha Jaiman M.D., M.P.H. | Chief Medical Officer |
Dr. Timothy J. Kieffer Ph.D. | Chief Scientific Officer |
Aardvark Therapeutics share price today is $5.86 as on at the close of the market. Aardvark Therapeutics share today touched a day high of $6 and a low of $5.6.
Aardvark Therapeutics share touched a 52 week high of $17.94 on and a 52 week low of $4.74 on . Aardvark Therapeutics stock price today i.e. is closed at $5.86,which is 67.34% down from its 52 week high and 23.63% up from its 52 week low.
Aardvark Therapeutics market capitalisation is $0.00T as on .
Indian investors can start investing in Aardvark Therapeutics (AARD) shares with as little as ₹91.708 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.08 in Aardvark Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Aardvark Therapeutics share’s latest price of $5.86 as on March 7, 2026 at 2:29 am IST, you will get 1.7065 shares of Aardvark Therapeutics. Learn more about
fractional shares .